Stereotaxis (STXS) Cash from Investing Activities Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -528.34% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -4.51% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -82.56% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 40.11% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | -6.30% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -420.31% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -104.07% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -14.95% |
| 10 | Stereotaxis | 187.40 Mn | 172.78 Mn | 3.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,400.00% |
| Sep 30, 2024 | 1,080.00% |
| Sep 30, 2023 | 95.12% |
| Jun 30, 2023 | 3,196.00% |
| Mar 31, 2023 | 69.76% |
| Dec 31, 2022 | -1,579.35% |
| Sep 30, 2022 | -301.96% |
| Jun 30, 2022 | -460.34% |
| Mar 31, 2022 | -3,294.12% |
| Dec 31, 2019 | -37.53% |
| Sep 30, 2019 | 96.98% |
| Mar 31, 2019 | 1.57% |
| Dec 31, 2018 | -4.56% |
| Sep 30, 2018 | -193.12% |
| Mar 31, 2018 | -132.49% |
| Dec 31, 2015 | -22.43% |
| Sep 30, 2015 | -13.20% |
| Dec 31, 2012 | 98.99% |
| Sep 30, 2012 | 95.22% |
| Jun 30, 2012 | 89.11% |
| Mar 31, 2012 | 75.29% |
| Dec 31, 2011 | 46.53% |
| Sep 30, 2011 | -530.11% |